SNF consolidated billing exclusions are the services and drugs that sit outside the Part A daily rate and are billed separately by the provider that furnishes them. CMS groups them into five major categories. For pharmacy, the items to watch are certain chemotherapy drugs, ESRD-related ESAs given with dialysis, hospice-related drugs, radioisotopes, certain blood clotting factors and covered vaccines.
Consolidated billing puts almost everything a Part A resident receives inside the facility's daily rate. Almost. A defined list of services and drugs sits outside the bundle and is paid separately. If one of those items lands on your pharmacy invoice, you may be paying for something Medicare pays another provider to furnish.
This guide covers what the exclusions are, how CMS maintains them, and the specific drug categories finance teams should watch.
What is SNF consolidated billing?
Under the SNF prospective payment system, Medicare pays the facility a per-diem rate for each covered Part A day. Consolidated billing requires the facility to bill Medicare for nearly all services its Part A residents receive, including services furnished by outside suppliers under arrangement. The facility then pays those suppliers. The rule appears at 42 CFR 411.15(p), and CMS maintains the operational detail on its SNF consolidated billing page.
Drugs are inside the bundle. That is why the pharmacy bills the facility, not Part D, for a Part A resident, as covered in who pays for drugs during a Part A stay. The exclusions are the exceptions.
What are the consolidated billing exclusion categories?
CMS publishes an annual update file that lists, by HCPCS code, what is excluded from or included in consolidated billing. Its 2026 general explanation groups the codes into five major categories.
| Category | What it covers | Why it matters for pharmacy |
|---|---|---|
| I. Services beyond the scope of a SNF | CT, MRI, cardiac catheterization, radiation therapy, angiography, outpatient surgery, emergency services and related ambulance trips | Drugs given as part of these hospital services are generally billed by the hospital |
| II. Services for specific beneficiaries | Dialysis and related services for ESRD residents, including EPO and Aranesp given with dialysis; hospice care for the terminal illness | ESRD-related ESAs and hospice-related drugs should not be on the facility's Part A invoice |
| III. Services by certified providers other than SNFs | Certain chemotherapy drugs, chemotherapy administration, radioisotopes, customized prosthetics, certain blood clotting factors | The main drug exclusions finance teams need to watch |
| IV. Preventive and screening services | Mammography, vaccines (pneumococcal, influenza, hepatitis B, COVID-19) and their administration, and other screenings | Covered vaccines are Part B benefits, billed separately, not paid from the Part A rate |
| V. Part B services included in consolidated billing | Physical, occupational and speech therapy | Not a drug issue; listed for completeness |
Beginning January 2026, CMS stopped listing some categories' codes in the Part A file and points to other CMS lists instead, including the vaccine pricing page for Category IV-B. The chemotherapy codes remain in the Part A file. Check the current year's files rather than relying on last year's spreadsheet.
What could your building recover?
Two numbers, instant estimate. No email needed.
Is all chemotherapy excluded from consolidated billing?
The chemotherapy exclusion is the one most often misunderstood. The Medicare Claims Processing Manual, Chapter 6, makes three points finance teams should know.
- Only listed codes qualify. The exclusion applies only to the specific chemotherapy codes CMS designates. These are high-intensity drugs that are not typically given in a SNF, are exceptionally expensive, or need special staff expertise. Chemotherapy drugs that are inexpensive and routinely given in SNFs stay inside the bundle.
- Supportive drugs stay in. Drugs that treat the side effects of chemotherapy, such as anti-emetics, remain subject to consolidated billing even when given alongside an excluded chemotherapy drug.
- Use matters. If a drug on the excluded chemotherapy list is prescribed for a purpose other than fighting cancer, it is no longer treated as an excluded chemotherapy drug.
In practice, that means an oral chemotherapy drug on your invoice is not automatically an error, and an anti-nausea drug billed alongside chemotherapy is not automatically excluded. Each line needs the code, the use and the date.
Are ESAs for dialysis residents excluded?
For residents with end-stage renal disease, dialysis and related services furnished by a renal dialysis facility are excluded. EPO (epoetin alfa) and Aranesp (darbepoetin alfa) have separate codes for ESRD and non-ESRD use. ESRD-related use furnished with dialysis is excluded. Non-ESRD use follows different billing rules (CMS 2026 general explanation).
If the dialysis facility is administering the ESA, the drug should not also appear on your pharmacy invoice.
Who pays for drugs for hospice residents?
When a resident elects hospice, care related to the terminal illness is billed by the hospice. Drugs related to the terminal illness are generally the hospice's responsibility under its own benefit. Drugs unrelated to the terminal illness follow the resident's other coverage. The facility should not be paying for hospice-related drugs out of its own budget unless a written arrangement says so.
What about blood clotting factors and radioisotopes?
These are low-volume, high-cost items. One line can equal a month of routine drug spend for a resident. When they appear, they deserve individual review against the current exclusion list. For bundled high-cost drugs, see high-cost drugs during a Part A stay.
How do you check an invoice for excluded drugs?
Run this on every line billed to the facility for a Part A resident.
- Flag high-cost lines. Anything above a threshold you set, for example the top 5 percent of line values.
- Map NDC to HCPCS. Exclusion lists use HCPCS codes. Pharmacy invoices use NDCs. A crosswalk is needed to compare them.
- Check the current year's list. CMS updates exclusions annually, and codes are added and removed. The CMS consolidated billing page holds the current files.
- Check the use. For chemotherapy codes, confirm the drug was used to treat cancer.
- Check who administered it. Dialysis-related drugs given at the dialysis facility, and hospice-related drugs, belong elsewhere.
- Document and ask. If an excluded item appears on your invoice, ask the pharmacy in writing how it was classified.
If you are new to the line fields, start with how to read an LTC pharmacy invoice.
Free · 48 hours · no integration
Get a free 48-hour pharmacy audit
- Send three files: invoices, census, contract
- See overbilling and Part A exposure, line by line
- BAA signed before any data moves
Why do consolidated billing errors matter now?
Consolidated billing errors cut both ways. Paying for an excluded drug costs the facility money. Billing a bundled drug to Part D or Part B creates compliance exposure. The OIG estimated that Part D paid up to $465.1 million from 2018 through 2020 for drugs for which payment was available under the Part A SNF benefit (OIG A-09-21-03008), and it has an open project on facilities' responsibility for those drugs. See what facilities should expect from the OIG's review.
Exposure scales with acuity. A short-stay or rehab-heavy facility with oncology or dialysis residents sees more of these lines. A management company overseeing several buildings needs a consistent rule set so every building classifies the same way.
Free report · New York editionThe Part A Pharmacy Report 202620 pages built from public CMS data: Part A days, drug cost estimates, the 20-point invoice checklist.Get the report
This article is general information, not legal or billing advice. Code-level decisions should follow current CMS files and your billing team's review.
Frequently asked questions
If a drug is excluded, who bills for it?
The provider that furnishes the excluded service bills Medicare for it, typically under Part B. The facility does not include it in its Part A claim and should not be paying for it out of its Part A rate. For how Parts A, B and D divide drug costs, see Part A, Part B or Part D.
Does the exclusion list apply to Medicare Advantage residents?
Consolidated billing is a rule of original Medicare. For Medicare Advantage residents, the facility's contract with the plan decides which drugs are inside the per diem and which the plan pays separately. Many plans borrow the original Medicare structure, but not all do. Read each contract's carve-out language; more in Medicare Advantage drug carve-outs in SNF contracts.
How often does the list change?
CMS updates the exclusion files at least annually, and has issued mid-year changes. In the October 2024 update, for example, CMS added codes for chemotherapy, customized prosthetic devices and certain blood clotting factors, and removed one chemotherapy code (AHCA/NCAL). A drug that was excluded last year may be bundled this year.
Does the pharmacy decide what is excluded?
The pharmacy decides who it bills. The rules decide who should pay. When the pharmacy classifies a line, the facility still carries the consequences, so it is worth checking the classification rather than assuming it.
Get the 48-hour first look
Send three months of invoices, your census and your pharmacy services agreement. We check every Part A line against the current exclusion lists and show you, within 48 hours, what you paid for that belongs elsewhere. Request your free 48-hour audit, or estimate the dollars involved with the savings calculator, which uses our working estimate, labeled as such.